Oncotarget: E6-specific inhibitors as therapeutics for HPV+ head and neck carcinomas

(Impact Journals LLC) "Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence."